Viewing Study NCT03624933


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-03-01 @ 10:11 AM
Study NCT ID: NCT03624933
Status: COMPLETED
Last Update Posted: 2023-09-05
First Post: 2018-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Cannabis Abstinence on Symptoms and Cognition in Depression
Sponsor: Centre for Addiction and Mental Health
Organization:

Study Overview

Official Title: Effects of Extended Cannabis Abstinence on Symptoms and Cognition in Depressed Individuals
Status: COMPLETED
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this study is to assess the changes in symptoms and cognition that occur after a 28-day abstinence period in patients with comorbid Cannabis Use Disorder (CUD) and Major Depression (MDD). This study employs a 28-day abstinence paradigm a total of 8 visits to the CAMH Russell site (screening, training, baseline, week 1, week 2, week 3, week 4, follow-up). Participants should be between the ages of 18-55, meet criteria for moderate depression and CUD, be non-treatment seeking, and be on a stable dose of antidepressant medication. The study visits will take up a total of approximately 22.5 hours with compensation for time provided. These visits will involve multiple clinical, substance use, and cognitive assessments. Abstinence will be maintained by weekly behavioural coaching sessions and contingency reinforcement.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: